Research

prison cell
September 26, 2013

New evaluation process offers better outcomes for juvenile offenders

Peabody researchers are partnering with juvenile justice systems around the country to improve outcomes for young offenders.

By VUMC News and Communications
syringe
September 19, 2013

VU testing vaccine against new flu threat

Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring.

By VUMC News and Communications
September 19, 2013

VU study brings genome’s ‘dark matter’ into light

Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the “dark matter” of the genome and has begun to explore a possible new approach to treating cancer.

By Bill Snyder
microscope
September 19, 2013

Lacy’s crystallographic research achievements recognized

D. Borden Lacy, Ph.D., associate professor of Pathology, Microbiology and Immunology, and Biochemistry, will receive the 2014 Margaret Etter Award from the American Crystallographic Association (ACA) for outstanding achievement and exceptional potential in crystallographic research demonstrated by a scientist at an early stage of their independent career.

By Nancy Humphrey
September 18, 2013

Free online course on data management for clinical research now underway

Vanderbilt University’s latest offering on the online learning platform Coursera, “Data Management for Clinical Research,” went live this week. More than 33,000 number of students have registered for the massive open online course or MOOC.

By VUMC News and Communications
September 18, 2013

Fishing for new anti-cancer drugs

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.

By Leigh MacMillan
September 16, 2013

Mapping brain membrane proteins

New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues.
By Leigh MacMillan
September 13, 2013

Cancer nanomedicines on target

Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time.
By Leigh MacMillan
September 12, 2013

VU study identifies DNA changes in drug-resistant cancer cells

Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.
By Leigh MacMillan
September 12, 2013

VU tracking drug’s ability to prevent type 1 diabetes

Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.
By VUMC News and Communications
September 12, 2013

Two named to National Academies’ advisory board

Vanderbilt University’s Roger D. Cone, Ph.D., and Elizabeth Heitman, Ph.D., have been appointed to the National Academies’ Board on Life Sciences, which advises the government and scientific community on a wide range of topics, from stem cell research to bioterrorism.
By Bill Snyder
September 12, 2013

Sleep education helps families of children with autism

Parent sleep education is beneficial in improving sleep and aspects of daytime behavior and family functioning in children with autism spectrum disorders (ASD), according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders.
By Craig Boerner
September 12, 2013

‘Proofreader’ key to coronavirus growth

A coronavirus protein is required for replication of the viral genome and may be a good treatment target for SARS and other diseases caused by coronaviruses.
By Leigh MacMillan
1 … 159 160 161 162 163 … 210